Biomarker Technologies Expands Hong Kong Operations, Attends Industry Conferences
Genomics firm Biomarker Technologies (BMKGene) has relocated its Hong Kong laboratory to larger facilities and participated in several international industry conferences to showcase its solutions.
Biomarker Technologies (BMKGene) has moved its Hong Kong laboratory to new, expanded premises within the Hong Kong-Shenzhen Innovation and Technology Park (HSITP). The relocation, effective April 9, 2026, enhances the company's operational capacity and supports its growth in the region.
The company has also been active at international genomics conferences. In January 2026, BMKGene attended the Plant and Animal Genome XXIII conference in San Diego, USA, where it presented its genomics solutions and fostered collaborations with researchers.
In October 2025, BMKGene showcased its multi-omics solutions for Agri-Environmental Science at the CANVAS 2025 event in Salt Lake City. Earlier that month, the company also participated in ASHG 2025 in Boston, highlighting advancements in genetics and engaging with the scientific community.
In August 2025, BMKGene presented its spatial genomics solutions at the ESEB 2025 congress in Barcelona, Europe's premier evolutionary biology event. The company has also supported ETH Zurich's research breakthrough in endosymbiosis, demonstrating its commitment to scientific advancement.
These activities underscore Biomarker Technologies' efforts to expand its service offerings and solidify its position as a global genomics provider, while promoting research and collaboration across scientific disciplines.